Trade Biogen Inc. - BIIB CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.39 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023624% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001401% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 123 |
| Open | 118.12 |
| 1-Year Change | -42.03% |
| Day's Range | 117.56 - 122.15 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 4, 2025 | 122.61 | -5.92 | -4.61% | 128.53 | 129.45 | 122.06 |
| Apr 3, 2025 | 130.28 | -0.97 | -0.74% | 131.25 | 132.87 | 129.89 |
| Apr 2, 2025 | 131.10 | -0.88 | -0.67% | 131.98 | 133.50 | 128.48 |
| Apr 1, 2025 | 131.86 | -4.57 | -3.35% | 136.43 | 136.90 | 131.19 |
| Mar 31, 2025 | 136.74 | -0.42 | -0.31% | 137.16 | 137.34 | 134.52 |
| Mar 28, 2025 | 137.90 | -2.35 | -1.68% | 140.25 | 140.90 | 137.90 |
| Mar 27, 2025 | 139.87 | -2.48 | -1.74% | 142.35 | 143.83 | 139.59 |
| Mar 26, 2025 | 142.22 | 3.09 | 2.22% | 139.13 | 142.79 | 138.98 |
| Mar 25, 2025 | 139.11 | -3.03 | -2.13% | 142.14 | 142.14 | 138.49 |
| Mar 24, 2025 | 141.37 | 0.00 | 0.00% | 141.37 | 143.94 | 140.43 |
| Mar 21, 2025 | 140.85 | -0.31 | -0.22% | 141.16 | 141.71 | 138.94 |
| Mar 20, 2025 | 140.95 | 0.00 | 0.00% | 140.95 | 142.76 | 140.31 |
| Mar 19, 2025 | 140.98 | -1.82 | -1.27% | 142.80 | 143.81 | 140.33 |
| Mar 18, 2025 | 143.00 | 0.05 | 0.03% | 142.95 | 145.63 | 142.63 |
| Mar 17, 2025 | 143.47 | 4.75 | 3.42% | 138.72 | 143.68 | 138.52 |
| Mar 14, 2025 | 139.07 | -0.01 | -0.01% | 139.08 | 140.61 | 138.29 |
| Mar 13, 2025 | 139.80 | 0.67 | 0.48% | 139.13 | 143.22 | 138.83 |
| Mar 12, 2025 | 139.99 | -1.91 | -1.35% | 141.90 | 142.84 | 139.76 |
| Mar 11, 2025 | 143.46 | -6.23 | -4.16% | 149.69 | 151.06 | 141.93 |
| Mar 10, 2025 | 150.46 | 0.41 | 0.27% | 150.05 | 156.88 | 149.95 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Biogen Company profile
Biogen Inc. (BIIB) is a biotechnology company in the field of neurological and neurodegenerative diseases.
Established in 1978 and headquartered in Cambridge, Massachusetts, Biogen has devoted its scientific research to defeating neurological diseases, like multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS).
With the aid of some of the world’s leading neuroscientists and neurologists, Biogen has sought treatments against common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
The use of advanced technologies and engineering skills has enabled Biogen to bring effective medicines to the market. The company’s products include SPINRAZA for the treatment of SMA; TECFIDERA, AVONEX, FAMPYRA, VUMERITY and TYSABRI for multiple sclerosis; ADUHELM for Alzheimer’s disease; and FUMADERM for the treatment of severe plaque psoriasis.
Biogen has made an agreement with Genentech, a member of the Roche Group for business and financial rights, with respect to RITUXAN, GAZYVA and OCREVUS. It’s constantly looking at ways to improve its research and development to compete against other biotech giants like Pfizer Inc (PFE), Johnson & Johnson (JNJ) and Amgen (AMGN).
Biogen went public in September 1991. It trades on the Nasqaq under the ticker ‘BIIB’.
| Industry: | Biopharmaceuticals |
225 Binney Street
CAMBRIDGE
MASSACHUSETTS 02142
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com